kwic
different
different
right
off
ON
26
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for different out of >500 occurrences
683276 occurrences (No.7 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to different]
683276 occurrences (No.7 in the rank) during 5 years in the PubMed. [cache]
| 26) The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical technologies. |
| PMID:35321374 DOI:10.47176/mjiri.35.141 |
| 2021 Medical journal of the Islamic Republic of Iran |
| * A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development. |
| - Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical technologies. Methods: Using scoping review method, we analyzed studies that investigated methods for assessing the impacts of emerging medical technologies on development. To find these studies, the Cochran Library, ISI Web of Knowledge, Embase, Ebsco and Pubmed databases from 2000 to 2018 were searched. The methodological quality of the studies was assessed using the STROBE Checklist. Two reviewers independently selected the qualified studies. Charting and collating the data were used based on the method proposed by Arksey and O'Malley. Results: Overall, 38 studies met the inclusion criteria. Sixteen methods were identified and put in five distinct categories: forecasting, Pro-HTA, Early-HTA, priority setting, and HHS were found to measure the impact of emerging technologies. The quality of these studies was acceptable. Few studies were conducted on emerging pharmaceutical technologies, and they were mostly on emerging medical devices. The Early HTA methods were often used to measure the effects of pharmaceutical technologies and medical devices technologies. The Pro-HTA method used dynamic modeling to examine the impact of medical technologies on a broad range of dimensions, while the HTA and Early-HTA methods used cost-effectiveness techniques throughout the development process. The HHS method used a multivariate decision-making technique. Conclusion: Different methods were used to investigate the impacts of emerging medical technologies. Chronologically Pro-HTA methods are new ways for investigating emerging medical technologies beyond clinical and economic impacts. Assessing the feasibility of implementing Pro-HTA in real environments deserves further research. |
[
right
kwic]
(1)21  types |
(18)3 combinations |
(35)2 applications |
(52)2 languages, |
| (2)8 methods |
(19)3 contexts |
(36)2 areas |
(53)2 levels: |
| (3)8 treatment |
(20)3 databases |
(37)2 between |
(54)2 lipid |
| (4)7 from |
(21)3 definitions |
(38)2 cell |
(55)2 methodological |
| (5)6 levels |
(22)3 developmental |
(39)2 cognitive |
(56)2 methods, |
| (6)6 studies |
(23)3 drugs |
(40)2 communities |
(57)2 modes |
| (7)5 aspects |
(24)3 interventions |
(41)2 components |
(58)2 movement |
| (8)5 in |
(25)3 models |
(42)2 concentrations |
(59)2 phenotypes |
| (9)5 settings |
(26)3 populations, |
(43)2 conditions |
(60)2 physical |
| (10)4 clinical |
(27)3 research |
(44)2 consensus |
(61)2 probiotics |
| (11)4 countries |
(28)3 scales |
(45)2 countries, |
(62)2 situations |
| (12)4 factors |
(29)3 surfaces |
(46)2 designs |
(63)2 stakeholders |
| (13)4 forms |
(30)3 than |
(47)2 diagnostic |
(64)2 study |
| (14)4 mechanisms |
(31)3 ways |
(48)2 environments |
(65)2 surface |
| (15)4 populations |
(32)2 DNA |
(49)2 ethnic |
(66)2 techniques |
| (16)4 strategies |
(33)2 UER |
(50)2 fields |
(67)2 tissues |
| (17)3 approaches |
(34)2 age |
(51)2 global |
add keyword
--- WordNet output for different ---